Last reviewed · How we verify
NCT04387994
Determination of Circulating Placental Biomarkers Levels to Predict the Pregnancy Outcome of First Trimester After IVF.
trial testing Blood samples collection in Infertility, Female in 120 participants. Completed in 7 December 2021.
7 December 2021
Quick facts
| Lead sponsor | Instituto Valenciano de Infertilidade de Lisboa |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 120 |
| Start date | 12 June 2020 |
| Primary completion | 7 December 2021 |
| Estimated completion | 7 December 2021 |
| Sites | 1 location across Portugal |
Drugs / interventions tested
- Blood samples collection — full drug profile →
Conditions studied
- Infertility, Female — all drugs for Infertility, Female →
- First Trimester Spontaneous Abortion — all drugs for First Trimester Spontaneous Abortion →
Sponsor
Instituto Valenciano de Infertilidade de Lisboa — full company profile →
Who can join
Adults 18 to 48, female only, with Infertility, Female or First Trimester Spontaneous Abortion. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study will assess the predictive potential of circulating placental biomarkers for spontaneous miscarriage within the following month in an IVF setting. It is hypothesized that a robust algorithm including one or more of these biomarkers may allow for the accurate same-day distinction between women with a low and high risk of a spontaneous miscarriage.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04387994
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Blood samples collection
Trials testing the same drug.
- NCT06451744 — Cellular and Molecular Biomarkers in Patients With Lichen Planus · NA · recruiting
- NCT05793008 — Characterization of priMary And sEcondary STress Related takOtsubo · NA · recruiting
- NCT04373200 — Human Ab Response & immunoMONItoring of COVID-19 Patients · NA · completed
- NCT05784584 — Early Anti-Retroviral Treatment in HIV- Infected Children · completed
Other recruiting trials for Infertility, Female
Currently open trials in the same condition.
- NCT06771401 — Identification of Biomarkers in Cervical Mucus · NA · recruiting
- NCT06984081 — CAPA In-vitro Oocyte Maturation · NA · recruiting
- NCT07308561 — The Relationship Between Quality of Life, Anxiety Levels, and Attitudes Toward Artificial Intelligence Among Women Under · recruiting
- NCT07175571 — SISTER: Sibling Oocyte Insemination With Frozen Sperm From Third Party Donors: Evaluation of Reproductive Techniques · NA · recruiting
- NCT06193135 — Usefulness of Corifollitropin α as Alternative to Conventional Daily rFSH Protocols in Oocyte Donors Undergoing Pituitar · NA · recruiting
Other Instituto Valenciano de Infertilidade de Lisboa trials
Trials by the same sponsor.
- NCT04849156 — Spermatozoa Morphology Selection by Thermotaxis · completed
- NCT05488236 — Nuclear Magnetic Resonance for Embryo Ploidy Selection · completed
- NCT04546412 — Importance of the Microtubule Cytoskeleton in Oocyte Competence · completed
- NCT03755973 — Effect of Different Ovarian Stimulation Protocols on Endometrial Receptivity · Phase 4 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04387994 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Instituto Valenciano de Infertilidade de Lisboa
- Last refreshed: 4 August 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04387994.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing